BlackRock Inc. - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 42 filers reported holding CATALYST BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$74,158
+37.3%
153,759
+0.1%
0.00%
Q2 2023$54,026
+53.6%
153,657
-9.6%
0.00%
Q1 2023$35,170
-62.8%
169,904
-5.3%
0.00%
Q4 2022$94,613
+5.1%
179,362
-0.1%
0.00%
Q3 2022$90,000
-71.3%
179,547
+1.8%
0.00%
Q2 2022$314,000
+86.9%
176,333
-30.5%
0.00%
Q1 2022$168,000
-28.5%
253,585
-1.4%
0.00%
Q4 2021$235,000
-78.9%
257,284
-5.0%
0.00%
Q3 2021$1,112,000
-9.2%
270,718
-4.3%
0.00%
Q2 2021$1,225,000
-85.3%
282,823
-82.9%
0.00%
Q1 2021$8,325,000
-2.1%
1,651,758
+22.6%
0.00%
Q4 2020$8,503,000
+54.9%
1,347,395
+5.6%
0.00%
Q3 2020$5,489,000
-13.9%
1,276,491
+17.5%
0.00%
Q2 2020$6,375,000
+419.6%
1,085,969
+286.8%
0.00%
Q1 2020$1,227,000
-33.6%
280,751
+3.5%
0.00%
Q4 2019$1,847,000
+38.7%
271,188
-0.1%
0.00%
Q3 2019$1,332,000
-34.5%
271,516
-1.7%
0.00%
Q2 2019$2,034,000
-69.5%
276,079
-66.5%
0.00%
Q1 2019$6,675,000
-0.1%
823,090
-2.8%
0.00%
Q4 2018$6,680,000
-23.3%
846,529
+4.8%
0.00%
Q3 2018$8,704,000
-4.0%
807,441
+3.9%
0.00%
Q2 2018$9,068,000
+88.8%
777,004
+317.4%
0.00%
Q1 2018$4,802,000
+103.0%
186,148
+7.3%
0.00%
Q4 2017$2,366,000
+169.8%
173,4630.0%0.00%
Q3 2017$877,000
+8.8%
173,4630.0%0.00%
Q2 2017$806,000
+805.6%
173,463
+1733.8%
0.00%
Q1 2017$89,0009,4590.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders